Compound Ivy Tablets

A technology of sinomenine and compound preparations, which is applied in the fields of medical formulas, organic active ingredients, bone diseases, etc., and can solve problems such as treating the symptoms but not the root cause, difficult to cure gout symptoms, and easy repeated exacerbations of gout

Inactive Publication Date: 2014-10-22
高玉珍
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current marketed drugs for the treatment of gout are difficult to cure gout symptoms. They treat the symptoms but not the root cause, and have relatively large toxic and side effects. Once the drug is stopped, gout is likely to recur and aggravate the attack

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound Ivy Tablets

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] The present invention uses more than 50 cases, taking 0.5-1.0 g of tablets or pills orally each time, three times a day, swallowing with 5% baking soda solution after meals, and taking it for 2-3 weeks, which has a good curative effect on gout ,

[0008] One week later, the concentration of uric acid in the blood was controlled within the normal range, and no toxic side effects occurred in any case. After taking the medicine, there has been no rebound phenomenon of uric acid concentration in the blood, ranging from half a year to more than a year.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound preparation for reducing the concentration of uric acid in the blood to treat gout, and concretely discloses a compound Caulis Sinomenii tablet. The tablet is characterized in that the components of the tablet and the proportions of the components are shown in the specification, and eight medicines which are the components are mixed according to the proportions to prepare the tablet or a pill. 0.5-1.0g of the tablet or the pill is orally taken each time, and is continuously taken three times a day after each meal for 2-3 weeks.

Description

1. Technical field [0001] The invention relates to a compound oral tablet, in particular to a compound preparation capable of reducing blood uric acid concentration and treating gout. 2. Background technology [0002] Gout is a common chronic disease. The current commercially available medicines for the treatment of gout are difficult to radically cure gout symptoms. They treat the symptoms but not the root cause, and have relatively large toxic and side effects. Once the medicine is stopped, the gout is likely to aggravate repeatedly. 3. Contents of the invention [0003] The technical problem to be solved by the invention is to overcome the deficiencies in the prior art and provide a safe, effective and oral natural medicine with less toxic and side effects. The present invention adopts sinomenine (its English name is Sinomenine, molecular formula is C 19 h 23 NO 4 , molecular weight is 329.38) as the basis, together with benzbromarone (its English name is Benzbromar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61K31/7034A61K31/585A61K31/557A61K31/485A61K31/37A61K31/343A61K31/047A61P19/06
Inventor 胡宝山刘庆博陆培群
Owner 高玉珍
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products